JNC guidelines classification scheme: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{CMG}}; {{AE}} {{Rim}} ==Overview== ==Evidence Quality Rating== ==Strength of Recommendation== ==References== {{Reflist|2}}")
 
Line 7: Line 7:


==Strength of Recommendation==
==Strength of Recommendation==
{| class="wikitable" border="1"
|-
|'''Grade''' || '''Strength of Recommendation''' || '''Explanation'''
|-
| '''A''' || Strong recommendation|| There is high certainty based on evidence that the net benefit is substantial.
|-
| '''B''' || Moderate recommendation||There is moderate certainty based on evidence that the net benefit is moderate to substantial or there is high certainty that the net benefit is moderate.
|-
| '''C''' || Weak recommendation||There is at least moderate certainty based on evidence that there is a small net benefit.
|-
| '''D''' || Recommendation against||There is at least moderate certainty based on evidence that it has no net benefit or that risks/harms outweigh
benefits.
|-
| '''E''' || Expert opinion||"There is insufficient evidence or evidence is unclear or conflicting, but this is what the committee recommends."<br> Net benefit is unclear. Balance of benefits and harms cannot be determined because of no evidence, insufficient evidence, unclear evidence, or conflicting evidence, but the committee thought it was important to provide clinical guidance and make a recommendation. Further research is recommended in this area.
|-
| '''N''' || No recommendation for or against||"There is insufficient evidence or evidence is unclear or conflicting."<br> Net benefit is unclear. Balance of benefits and harms cannot be determined because of no evidence, insufficient evidence, unclear evidence, or conflicting evidence, and the committee thought no recommendation should be made. Further research is recommended in this area.
|-
|}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 19:49, 18 December 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Evidence Quality Rating

Strength of Recommendation

Grade Strength of Recommendation Explanation
A Strong recommendation There is high certainty based on evidence that the net benefit is substantial.
B Moderate recommendation There is moderate certainty based on evidence that the net benefit is moderate to substantial or there is high certainty that the net benefit is moderate.
C Weak recommendation There is at least moderate certainty based on evidence that there is a small net benefit.
D Recommendation against There is at least moderate certainty based on evidence that it has no net benefit or that risks/harms outweigh

benefits.

E Expert opinion "There is insufficient evidence or evidence is unclear or conflicting, but this is what the committee recommends."
Net benefit is unclear. Balance of benefits and harms cannot be determined because of no evidence, insufficient evidence, unclear evidence, or conflicting evidence, but the committee thought it was important to provide clinical guidance and make a recommendation. Further research is recommended in this area.
N No recommendation for or against "There is insufficient evidence or evidence is unclear or conflicting."
Net benefit is unclear. Balance of benefits and harms cannot be determined because of no evidence, insufficient evidence, unclear evidence, or conflicting evidence, and the committee thought no recommendation should be made. Further research is recommended in this area.

References